Lucijanić, M., Tomasović Lončarić, Č., Štoos Veić, T., De Both, T., Jalšenjak, B. & Kušec, R. (2023). Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine. Annals of Hematology, 103. (2), 671-672. doi: 10.1007/s00277-023-05529-3

Lucijanić, Marko, et al. "Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine." Annals of Hematology, vol. 103, no. 2, 2023, pp. 671-672. https://doi.org/10.1007/s00277-023-05529-3

Lucijanić, Marko, Čedna Tomasović Lončarić, Tajana Štoos Veić, Tomislav De Both, Barbara Jalšenjak and Rajko Kušec. "Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine." Annals of Hematology 103, no. 2 (2023): 671-672. https://doi.org/10.1007/s00277-023-05529-3

Lucijanić, M., et al. (2023) 'Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine', Annals of Hematology, 103(2), pp. 671-672. doi: 10.1007/s00277-023-05529-3

Lucijanić M, Tomasović Lončarić Č, Štoos Veić T, De Both T, Jalšenjak B, Kušec R. Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine. Annals of Hematology [Internet]. 2023 February [cited 2024 July 14];103(2):671-672. doi: 10.1007/s00277-023-05529-3

M. Lucijanić, Č. Tomasović Lončarić, T. Štoos Veić, T. De Both, B. Jalšenjak and R. Kušec, "Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine", Annals of Hematology, vol. 103, no. 2, pp. 671-672, February 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:998089. [Accessed: 14 July 2024]